Phase-II-study with bendamustine/carboplatin in untreated patients with extensive disease small cell lung cancer.

被引：0
|
作者：
Koester, W
Stamatis, G
Niederle, N
Heider, A
Avramidis, K
Wilke, H
Stahl, M
机构：
[1] Kliniken Essen Mitte, Essen, Germany
[2] Ruhrlandklin, Essen, Germany
[3] Dept Hematol & Oncol, Leverkusen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7265
引用
收藏
页码：682S / 682S
页数：1
相关论文
共 50 条
  • [21] A phase II study of pembrolizumab and paclitaxel in refractory extensive disease small cell lung cancer.
    Kim, YuJung
    Keam, Bhumsuk
    Ock, Chan-Young
    Song, Sanghoon
    Kim, Miso
    Kim, Se Hyun
    Kim, Ki Hwan
    Kim, Jin-Soo
    Kim, Tae Min
    Kim, Dong-Wan
    Lee, Jong Seok
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive stage small-cell lung cancer
    Fukuda, M.
    Nakamura, Y.
    Kasai, T.
    Kinoshita, A.
    Fukuda, M.
    Motoshima, K.
    Iida, T.
    Nakatomi, K.
    Soda, H.
    Oka, M.
    Kohno, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] PHASE I/IIA STUDY OF THE NOVEL COMBINATION OF BENDAMUSTINE PLUS IRINOTECAN FOLLOWED BY ETOPOSIDE PLUS CARBOPLATIN IN UNTREATED PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
    Grant, Stefan C.
    Allendorf, Daniel J.
    Bordani, Rodolfo
    Saleh, Mansoor
    Jerome, Mary
    Miley, Debi
    Cantor, Alan
    Reddy, Vishnu
    Robert, Francisco
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S636 - S636
  • [24] A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer CALGB 30104
    Govindan, Ramaswamy
    Wang, Xiaofei
    Baggstrom, Maria Q.
    Burdette-Radoux, Susan
    Hodgson, Lydia
    Vokes, Everett E.
    Green, Mark R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 220 - 226
  • [25] A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
    Horn, Leora
    Zhao, Zhiguo
    Sandler, Alan
    Johnson, David
    Shyr, Yu
    Wolff, Steven
    DeVore, Russell F.
    Laskin, Janessa
    CLINICAL LUNG CANCER, 2011, 12 (03) : 161 - 165
  • [26] PHASE-II STUDY OF VP-16 AND CARBOPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC)
    EVANS, W
    EISENHAUER, E
    HUGHES, P
    SHEPHERD, F
    FELD, R
    AYOUB, J
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B109 - B109
  • [27] Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer.
    Socinski, MA
    Weissman, C
    Hart, LL
    Choksi, JK
    Holladay, C
    Prager, D
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [28] Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study
    Gridelli, C
    Ianniello, G
    Brancaccio, L
    Perrone, F
    Iaffaioli, RV
    Curcio, C
    DAprile, M
    Cioffi, R
    Cigolari, S
    Rossi, A
    Rinaldi, L
    Palazzolo, G
    Garcia, M
    Guida, C
    Bianco, AR
    Pergola, M
    Monfardini, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1047 - 1047
  • [29] Irinotecan, carboplatin and etoposide regimen in extensive disease small cell lung cancer: Phase II trial
    Syrigos, K.
    Katirtzoglou, N.
    Charpidou, A.
    Botsis, T.
    Karapanagiotou, E.
    Dilana, K.
    Gkiozos, I.
    Pantazopoulos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
    A Kinoshita
    M Fukuda
    H Soda
    S Nagashima
    M Fukuda
    H Takatani
    M Kuba
    Y Nakamura
    J Tsurutani
    S Kohno
    M Oka
    British Journal of Cancer, 2006, 94 : 1267 - 1271
12345